{"url_path":"/sec/humaw/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1818382/0001193125-26-221755-index.html","accession_number":"0001193125-26-221755","cik":"0001818382","ticker":"HUMA","issuer_name":"Humacyte, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1818382/0001193125-26-221755-index.html","primary_entity_key":"0001818382","primary_entity_name":"Humacyte, Inc."},"word_count":29,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings\n\nSee the section “Legal Matters” contained in Note 10, Commitments and Contingencies, in the notes to our accompanying condensed consolidated financial statements for additional information."}